Literature DB >> 26968532

RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature.

Vincent-Philippe Lavallée1, Sébastien Lemieux2, Geneviève Boucher3, Patrick Gendron3, Isabel Boivin3, Richard N Armstrong3, Guy Sauvageau4, Josée Hébert4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26968532     DOI： 10.1182/blood-2016-03-703868

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  23 in total

1.  The genomic landscape of core-binding factor acute myeloid leukemias.

Authors:  Zachary J Faber; Xiang Chen; Amanda Larson Gedman; Kristy Boggs; Jinjun Cheng; Jing Ma; Ina Radtke; Jyh-Rong Chao; Michael P Walsh; Guangchun Song; Anna K Andersson; Jinjun Dang; Li Dong; Yu Liu; Robert Huether; Zhongling Cai; Heather Mulder; Gang Wu; Michael Edmonson; Michael Rusch; Chunxu Qu; Yongjin Li; Bhavin Vadodaria; Jianmin Wang; Erin Hedlund; Xueyuan Cao; Donald Yergeau; Joy Nakitandwe; Stanley B Pounds; Sheila Shurtleff; Robert S Fulton; Lucinda L Fulton; John Easton; Evan Parganas; Ching-Hon Pui; Jeffrey E Rubnitz; Li Ding; Elaine R Mardis; Richard K Wilson; Tanja A Gruber; Charles G Mullighan; Richard F Schlenk; Peter Paschka; Konstanze Döhner; Hartmut Döhner; Lars Bullinger; Jinghui Zhang; Jeffery M Klco; James R Downing
Journal:  Nat Genet       Date:  2016-10-31       Impact factor: 38.330

2.  Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia.

Authors:  A-K Eisfeld; J Kohlschmidt; S Schwind; D Nicolet; J S Blachly; S Orwick; C Shah; M Bainazar; K W Kroll; C J Walker; A J Carroll; B L Powell; R M Stone; J E Kolitz; M R Baer; A de la Chapelle; K Mrózek; J C Byrd; C D Bloomfield
Journal:  Leukemia       Date:  2016-11-15       Impact factor: 11.528

3.  Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.

Authors:  Sanne Noort; Martin Zimmermann; Dirk Reinhardt; Wendy Cuccuini; Martina Pigazzi; Jenny Smith; Rhonda E Ries; Todd A Alonzo; Betsy Hirsch; Daisuke Tomizawa; Franco Locatelli; Tanja A Gruber; Susana Raimondi; Edwin Sonneveld; Daniel K Cheuk; Michael Dworzak; Jan Stary; Jonas Abrahamsson; Nira Arad-Cohen; Malgorzata Czogala; Barbara De Moerloose; Henrik Hasle; Soheil Meshinchi; Marry van den Heuvel-Eibrink; C Michel Zwaan
Journal:  Blood       Date:  2018-08-27       Impact factor: 22.113

Review 4.  Regulation of hematopoietic development by ZBTB transcription factors.

Authors:  Takahiro Maeda
Journal:  Int J Hematol       Date:  2016-06-01       Impact factor: 2.490

5.  RNAmut: robust identification of somatic mutations in acute myeloid leukemia using RNA-sequencing.

Authors:  Muxin Gu; Maximillian Zwiebel; Swee Hoe Ong; Nick Boughton; Josep Nomdedeu; Faisal Basheer; Yasuhito Nannya; Pedro M Quiros; Seishi Ogawa; Mario Cazzola; Roland Rad; Adam P Butler; M S Vijayabaskar; George S Vassiliou
Journal:  Haematologica       Date:  2019-10-24       Impact factor: 9.941

6.  SETBP1 overexpression acts in the place of class-defining mutations to drive FLT3-ITD-mutant AML.

Authors:  Suruchi Pacharne; Oliver M Dovey; Jonathan L Cooper; Muxin Gu; Mathias J Friedrich; Sandeep S Rajan; Maxim Barenboim; Grace Collord; M S Vijayabaskar; Hannes Ponstingl; Etienne De Braekeleer; Ruben Bautista; Milena Mazan; Roland Rad; Konstantinos Tzelepis; Penny Wright; Malgorzata Gozdecka; George S Vassiliou
Journal:  Blood Adv       Date:  2021-05-11

7.  Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome.

Authors:  C Y Cher; G M K Leung; C H Au; T L Chan; E S K Ma; J P Y Sim; H Gill; A K W Lie; R Liang; K F Wong; L L P Siu; C S P Tsui; C C So; H W W Wong; S F Yip; H K K Lee; H S Y Liu; J S M Lau; T H Luk; C K Lau; S Y Lin; Y L Kwong; A Y H Leung
Journal:  Blood Cancer J       Date:  2016-07-08       Impact factor: 11.037

8.  Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia.

Authors:  Eric Wang; Sydney X Lu; Alessandro Pastore; Xufeng Chen; Jochen Imig; Stanley Chun-Wei Lee; Kathryn Hockemeyer; Yohana E Ghebrechristos; Akihide Yoshimi; Daichi Inoue; Michelle Ki; Hana Cho; Lillian Bitner; Andreas Kloetgen; Kuan-Ting Lin; Taisuke Uehara; Takashi Owa; Raoul Tibes; Adrian R Krainer; Omar Abdel-Wahab; Iannis Aifantis
Journal:  Cancer Cell       Date:  2019-02-21       Impact factor: 31.743

9.  ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation.

Authors:  Luise Hartmann; Sayantanee Dutta; Sabrina Opatz; Sebastian Vosberg; Katrin Reiter; Georg Leubolt; Klaus H Metzeler; Tobias Herold; Stefanos A Bamopoulos; Kathrin Bräundl; Evelyn Zellmeier; Bianka Ksienzyk; Nikola P Konstandin; Stephanie Schneider; Karl-Peter Hopfner; Alexander Graf; Stefan Krebs; Helmut Blum; Jan Moritz Middeke; Friedrich Stölzel; Christian Thiede; Stephan Wolf; Stefan K Bohlander; Caroline Preiss; Linping Chen-Wichmann; Christian Wichmann; Maria Cristina Sauerland; Thomas Büchner; Wolfgang E Berdel; Bernhard J Wörmann; Jan Braess; Wolfgang Hiddemann; Karsten Spiekermann; Philipp A Greif
Journal:  Nat Commun       Date:  2016-06-02       Impact factor: 14.919

10.  METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation.

Authors:  Esteban A Orellana; Qi Liu; Eliza Yankova; Mehdi Pirouz; Etienne De Braekeleer; Wencai Zhang; Jihoon Lim; Demetrios Aspris; Erdem Sendinc; Dimitrios A Garyfallos; Muxin Gu; Raja Ali; Alejandro Gutierrez; Sigitas Mikutis; Gonçalo J L Bernardes; Eric S Fischer; Allan Bradley; George S Vassiliou; Frank J Slack; Konstantinos Tzelepis; Richard I Gregory
Journal:  Mol Cell       Date:  2021-08-04       Impact factor: 19.328
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.